We tend to associate hot flashes to women at the time of menopause. However, the condition affects men as well.
In both men and women, hormones are to blame. About 70% of women get hot flashes at the time of menopause, when estrogen levels plummet.
In men, the problem is testosterone. Normally, men don’t experience an abrupt drop in the hormone. In fact, although testosterone levels trickle down by about 1% a year after the age of 40, most men maintain levels within the normal range, and nearly all retain enough testosterone to prevent hot flashes.
The exception is men who’ve received hormonal therapy for prostate cancer that shuts down the production of testosterone. The growth of prostate cells is stimulated by testosterone, and treatments that reduce levels of the hormone or block its actions in the body can help treat the disease. Androgen deprivation can be a temporary measure to boost the effect of radiation therapy or it can be a long-term treatment for advanced prostate cancer. In the past, this was accomplished by surgically removing the testicles or by administering estrogen pills. As of mid-2005, though, treatment usually relies on injections that reduce testosterone production, such as leuprolide (Lupron) or goserelin (Zoladex), or drugs that block testosterone’s effects on tissues, such as bicalutamide (Casodex).
About 70%–80% of men who receive androgen deprivation therapy experience hot flashes.
Hot flashes feel the same to men and women: A sudden feeling of warmth or flushing that is most intense over the head and trunk, often accompanied by visible redness of the skin and by sweating, which can be profuse. Hot flashes are most common at night. They are usually brief, averaging four minutes, but often leave cold sweat behind. Flashes may be infrequent and mild or quite troublesome, sometimes occurring 6 to 10 times a day. Some people, both male and female, report anxiety, palpitations, or irritability.
Men who develop flashes during temporary androgen deprivation usually recover within three or four months of stopping treatment. However, most men don’t get over the hot flashes. In one study, over 40% of men still had flashes after more than 8 years of treatment. In another, 72% of patients said the hot flashes interfered with sleep and 59% reported they interfered with the ability to enjoy life. Fortunately, new treatments can help.
Men with prostate cancer cannot take testosterone, but they can use female hormones for hot flashes. In one study, 83% of men who tried estradiol (an estrogen) reported relief. But more than 40% experienced breast swelling or tenderness, and the trial was too brief to exclude the possibility of cardiovascular side effects. Similar studies of megestrol (Megace) and medroxyprogesterone (Provera), both members of the other group of female hormones (progesterones), have reported about 80%–90% reductions in hot flashes. But the side effects can include bloating and weight gain; in addition, the hormone appears to increase PSA levels in some patients.
Hormones can help, but newer treatments may be just as successful with fewer side effects. Two approaches have helped both men and women. One involves antidepressants. Selective serotonin reuptake inhibitors (SSRIs) such as paroxetine (Paxil) have been effective, as has a related antidepressant, venlafaxine (Effexor). Both types are well tolerated; venlafaxine can sometimes raise the blood pressure, and SSRIs can cause sexual dysfunction, but that’s not an issue for most men on androgen deprivation.
The other recent treatment uses the antiseizure medication gabapentin (Neurontin). The first reports of success were in men, but it rapidly gained wider use in women. In one study, the drug reduced the severity and frequency of hot flashes in women by 70%; dizziness is the most common side effect.
Bottom Line: Men are not immune to hot flashes. It is most common in men being treated for prostate cancer. Help is available. Let you doctor know that this is a problem and often the hot flashes can be cured or certainly can be controlled.